Cable One extends closing date for Mega Broadband deal
Cable One, Inc. extends the closing date for its acquisition of Mega Broadband Investments, reflecting strategic adjustments in a competitive market.
SouthState Bank Corp to Release Q3 Earnings on October 21
SouthState Bank Corp announces its Q3 earnings release date, set for October 21, 2026, highlighting its commitment to investor engagement.
Hepion Pharmaceuticals increases authorized shares to 750M
Hepion Pharmaceuticals amends its Certificate of Incorporation to raise authorized shares to 750 million, enhancing growth potential in the pharmaceutical sector.
TIAA Real Estate Account Issues $150 Million in Notes
TIAA Real Estate Account has entered a note purchase agreement to issue $150 million in senior notes, enhancing its financial flexibility.
First Community Corp CEO J. Ted Nissen to Retire in 2026
First Community Corp announces CEO J. Ted Nissen's retirement effective December 31, 2026, with plans for a consulting agreement for transition support.
Alpha Modus Holdings Receives Nasdaq Compliance Notice
Alpha Modus Holdings must show compliance with Nasdaq rules to avoid delisting, highlighting challenges in the patent ownership sector.
Tesla reports strong Q3 2026 production and delivery numbers
Tesla, Inc. reports over 464,000 vehicle productions and 486,000 deliveries in Q3 2026, showcasing its leadership in the motor vehicle industry.
UMH Properties declares quarterly dividends for shareholders
UMH Properties, Inc. declares quarterly dividends on common and preferred stock, highlighting financial stability in the real estate investment trust sector.
Scientific Industries extends key employment agreements
Scientific Industries Inc. has extended employment agreements for key executives, ensuring leadership stability in the laboratory analytical instruments sector.
Freeport-McMoRan reports third-quarter 2026 results
Freeport-McMoRan provides third-quarter 2026 operational update, showing steady copper and gold production and plans for future growth.
Hub Group announces board restructuring and new appointments
Hub Group, Inc. restructures its board, removing three directors and appointing four new members to enhance governance and strategic direction.
Muzinich Corporate Lending Income Fund sells $3M in stock
Muzinich Corporate Lending Income Fund, Inc. announces a $3 million stock sale, indicating a strategic financial move for the investment fund.
Blue Owl Technology Income Corp. Issues Shareholder Update
Blue Owl Technology Income Corp. shares strong performance in a recent update, highlighting stability in tender results and ongoing distributions through November 2026.
Rivian reports Q3 2026 production and delivery figures
Rivian Automotive announces Q3 2026 production of 19,751 vehicles and delivery of 19,248, reaffirming its annual delivery guidance amid industry competition.
Blue Owl Credit Income reports decline in share repurchase requests
Blue Owl Credit Income Corp. reports a decrease in share repurchase requests, indicating a stabilizing market for the company and the financial services sector.
Thunder Bridge Capital Partners V Announces Trading Changes
Thunder Bridge Capital Partners V, Ltd. allows separate trading of its Class A shares and warrants starting October 5, 2026, enhancing investor liquidity.
Bally's Corp secures $400 million financing for Bronx project
Bally's Corp has closed a $400 million loan to fund its Bronx project, enhancing its position in the hotels and motels industry.
OpenWorld, Inc. amends merger details in SEC filing
OpenWorld, Inc. corrects share issuance details in SEC filing post-merger with Legacy OpenWorld, impacting the finance services sector.
Quince Therapeutics Announces Board Resignations, New Appointments
Quince Therapeutics announces leadership changes with resignations and new appointments ahead of a critical stockholder meeting.
CNS Pharmaceuticals amends equity plan, elects new directors
CNS Pharmaceuticals updates its equity plan and elects new directors at the annual meeting, signaling ongoing growth in the pharmaceutical sector.